Intention-to-treat analysis: difference between revisions
Diff·revision 15 → 16·16:52, 22 Jul 2025
Difference between revision 15 and revision 16 of Intention-to-treat analysis. 2 lines changed; the page grew by 326 bytes.
| Revision 15 — 18:33, 21 Jun 2025 TFA_Counterion (talk) add the number randomised and the number completing 4,637 bytes ±0 | Revision 16 — 16:52, 22 Jul 2025 CiteBot (talk) bot: expand DOI to full citation 4,963 bytes +326 | ||
|---|---|---|---|
| 38 | Two are common in this field. The ''treatment policy'' estimand asks what happens when treatment is initiated, counting all data regardless of adherence; the ''trial product'' estimand asks what happens if treatment is taken as directed throughout. The second gives larger effects, and the two are frequently reported side by side.{{r|wilding2021}} | 38 | Two are common in this field. The ''treatment policy'' estimand asks what happens when treatment is initiated, counting all data regardless of adherence; the ''trial product'' estimand asks what happens if treatment is taken as directed throughout. The second gives larger effects, and the two are frequently reported side by side.{{r|wilding2021}} |
| 39 | 39 | ||
| + | 40 | Neither is more correct. They answer different questions, and a secondary source quoting one without saying which is quoting a number without its definition. This is why [[STEP trial programme|STEP]] and [[SURMOUNT trial programme|SURMOUNT]] figures sometimes differ between sources reporting the same trial.{{r|hollis1999}} | |
| + | 41 | ||
| 40 | == References == | 42 | == References == |
| 41 | {{reflist}} | 43 | {{reflist}} |